1hon MSNOpinion
‘Dumb money is chasing dumb IPOs’: Shankar Sharma on India's public markets amid Lenskart buzz
Veteran investor Shankar Sharma slams India's IPO market as the "dumbest in history," citing Lenskart's pre-IPO activity. He ...
The AI boom is visible from orbit. Satellite photos of New Carlisle, Indiana, show greenish splotches of farmland transformed ...
Ridham Desai warns being bullish doesn't mean markets will generate positive returns every year and investors should invest in equities with a long-term horizon ...
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily ...
Ritz-Carlton Yacht Collection is considering an IPO within two to three years, but may also be acquired by a larger cruise ...
Just a day after rolling out its MetaMask rewards program, which now begs the question—how will they balance an IPO and a ...
Crypto presale prediction points to IPO Genie ($IPO) as the next big crypto presale of 2025. Learn why investors are calling ...
Apollo, KKR and others turbo-charged their credit divisions by selling annuities. It drove a surge in sales of the retirement ...
Every bull run brings new promises. Some call them “the next big thing,” others call them “the next bubble.” In 2025, crypto ...
A breakdown of Citic Securities' fee income shows how the overall equity market boom in China and Hong Kong is helping the ...
Discover why Incyte Corporation is a top Buy with robust Q3 2025 results, pipeline advances, and promising oncology data.
Medline disclosed on Tuesday that its revenue rose 9.7% in the first half of 2025, as one of the world's largest makers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results